Innovation.
Quality.
Scale.

Proudly manufactured in the USA

MaximBio delivers integrated, U.S.-based development and manufacturing for lateral flow, molecular, and immunoassay diagnostics—combining deep scientific expertise with proven operational scale to accelerate your path from concept to commercialization.

WHAT WE DO

End-to-End Diagnostic Development & Manufacturing

Our integrated services enable excellence at every step of the diagnostics lifecycle - from early-stage assay development to full-scale production and fulfillment.

Assay Development

Antibody screening, selection, and conjugation

Custom reagent and buffer formulation

Product design, engineering, and system integration

Prototype and pilot-scale production

Lateral flow, molecular, and immunoassay formats

Clinical and regulatory strategy support

Manufacturing

Scalable production of lateral flow, ELISA, and custom immunoassays

Reagent formulation and dispensing

Device assembly and packaging

In-process and final quality control testing

Fulfillment, warehousing, and logistics

ISO-certified, environmentally controlled, FDA-registered U.S. facility

MaximBio Products

Developed and Manufactured in the USA

High-impact diagnostic tests addressing critical public health needs

Designed for accuracy, accessibility, and ease of use

Branded and private label solutions for retail, clinical, and government channels

Trusted partner to federal, state, and commercial healthcare programs

Over 20 Years of Trusted R&D Partnerships in IVD

For more than two decades, we've collaborated with leading healthcare companies and U.S. government agencies to bring high-quality diagnostics from concept to market. Our R&D team has solved some of the industry's toughest assay challenges for partners ranging from early-stage innovators to global industry leaders—turning ambitious ideas into commercially successful products.

Commercial-Scale Manufacturing, Built in the USA

From our FDA-registered, ISO 13485-certified facility in Rockville, Maryland, we produce millions of diagnostic tests each month for partners that demand precision, compliance, and consistent performance. Our automated production lines, controlled environments, and mature quality systems are engineered to meet the demands of regulated markets at any scale.

ABOUT US

Serving the Fortune 100 and Emerging Diagnostic Innovators

Maxim Biomedical supports its partners' success with world-class IVD development and manufacturing expertise.

Deep Scientific Expertise

Scientific depth and innovation to solve the toughest assay development problems

End-to-End Continuity

Seamless development-to-manufacturing execution under one roof

Family-Led Values

Backed by personal commitment and accountability

Built to Serve Science and Scale

FDA-Registered Facility | ISO 13485:2016

ISO 5/7/8 Cleanrooms | Biochemistry & Dry Rooms

World-Class Quality Infrastructure for Regulatory Success

Scalable, Compliant Manufacturing for Regulated Markets

MaximBio is Trusted when Success is Required

CASE STUDY

Pandemic Response at Speed

From Concept to 22+ Million Tests Delivered for the U.S. Government

In response to the urgent national need during the COVID-19 pandemic, MaximBio partnered with the NIH RADx initiative and the Department of Defense to develop and deliver the ClearDetect® COVID-19 Antigen Home Test.

  • Full Lifecycle Execution: MaximBio led the end-to-end development—spanning R&D, regulatory submission, and EUA approval—delivering a fully realized diagnostic product at unprecedented speed.
  • High-Volume Manufacturing: Over 22 million tests were produced for U.S. government distribution, including 8 million tests in less than 4 months, demonstrating agile scale-up and manufacturing resilience.
  • Proven Performance Under Pressure: This initiative highlighted MaximBio’s ability to mobilize quickly and meet complex regulatory, technical, and operational demands—delivering speed, scale, and quality when it mattered most.
CASE STUDY

Class III Diagnostics - Built for Trust, Backed by Quality

A 15+ Partnership Supporting a Global Industry Leader

For over 15 years, MaximBio has served as a trusted development and manufacturing partner for Class III, BLA-regulated diagnostic products - among the most complex and highly regulated in the diagnostics space.

  • Regulatory & Quality Excellence: Supporting a partner with global scale and exacting standards, MaximBio has established and maintained robust FDA BLA-compliant systems, including end-to-end documentation control and quality infrastructure designed for the highest levels of regulatory scrutiny.
  • Long-Term Reliability: We ensure consistent, high-quality manufacturing that supports global distribution of high-value diagnostics - where precision, compliance, and performance are critical.
  • Built for Scale and Rigor: This long-standing partnership reflects MaximBio’s ability to meet the demands of a top-tier diagnostics program, from Technical Transfer through sustained, commercial-scale production.

Your Diagnostic Partner at Every Step

Whether you're just getting started or scaling up manufacturing, MaximBio works as a true extension of your team—bringing deep expertise, flexible support, and a shared commitment to helping you succeed.